ABBV vs V: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Visa Inc. · Financial Services
$368.29
+25.7% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
V has more upside to fair value
(+25.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
V |
| Current Price |
$261.70 |
$368.29 |
| Fair Value Estimate |
$259.04 |
$463.00 |
| Upside to Fair Value |
-1.0%
|
+25.7%
|
| Market Cap |
$462.4B |
$687.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
24.0x
|
| Price / Sales |
7.2x
|
15.5x
|
| Price / FCF |
23.6x
|
33.5x
|
| Revenue Growth YoY |
+10.2%
|
+14.4%
|
| Gross Margin |
71.5%
|
80.2%
|
| Operating Margin |
29.3%
|
60.7%
|
| Return on Equity |
-136.5%
|
61.3%
|
| Dividend Yield |
2.61% |
0.73% |
| FCF Yield |
4.25%
|
2.98%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Visa operates the world's largest retail payments network, connecting consumers, merchants, issuers, and acquirers through VisaNet, which authorizes, clears, and settles transactions across more than 200 countries. The business quality is exceptional: TTM gross margin of 80.2%, operating margin of 60.7%, net margin of 50.8%, and ROE of 61.3% reflect a two-sided network with powerful scale economi…
Accumulation Zones
| Metric |
ABBV |
V |
| Zone Low |
$194.28 |
$347.25 |
| Zone High |
$220.18 |
$393.55 |
| In Buy Zone? |
No
|
Yes
|